Recent Event

<>

June 19, 2017 - June 22, 2017

San Diego, CA

2017 BIO International Convention

Panelist: Roger Longman

Real Endpoints LLC

Value assessment frameworks are a relatively new concept designed to help stakeholders determine what treatments provide the most value in healthcare. They are sometimes influential in determining what therapies are chosen by patients and their doctors, and often used to determine if those therapies will be covered and reimbursed by payers. How these frameworks consider personalized medicine is not yet clear. Designed before 25% of all new drugs were personalized medicines, value frameworks might need to evolve to keep pace with scientific discovery and recognize the leading role of diagnostic testing in targeting therapeutic use. This session will examine how value assessment frameworks have been developed historically, examine the current critiques of their processes and methodologies and explore how they might have to change in the future to support personalized medicine.

view event >

Recent Events

October 2, 2019 1:15pm

San Diego, CA

Roger Longman

Real Endpoints

Real Endpoints Founder, Roger Longman, is looking forward to leading a robust discussion focused on solutions to creating access to cell and gene therapies — solutions that work for both payers and biopharma.

view event >

May 31, 2019

Waldorf Astoria Chicago Hotel

5th Annual Immuno-Oncology BD&L and Investment Forum

Speaker: Roger Longman

Real Endpoints

Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment. Numerous networking opportunities available via an online one-to-one meeting system with dedicated meeting facilities to make the event more transactional.

May 14, 2019 9:30am ET

Financial District, New York, NY

Panelist: Jeff Berkowitz

Real Endpoints

PANEL DISCUSSION I: Impact of Pricing and Policy on the Next Decade of Therapeutic Innovation

view event >

March 25, 2019 3:20pm

San Diego Convention Center, CA

Jane Barlow, MD, MPH, MBA

Real Endpoints

Innovative and novel financing and reimbursement strategies may be needed to support sustainable patient access to these new treatments. During this session, managed care and provider strategies for addressing gene therapy will be explored.

view event >

March 25, 2019 4:20pm

San Diego Convention Center, CA

Jane Barlow, MD, MPH, MBA

Real Endpoints

The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders. During this panel discussion, participants will have the opportunity to hone in on pressing issues raised throughout the conference and discuss these issues with a panel of experts with varying backgrounds, including both clinical and managed care perspectives.

view event >

February 12, 2019 1:30 pm ET

New York Marriott Marquis

Panelist: Roger Longman

Real Endpoints

Departure from traditional dosage-based models makes it difficult for therapy developers, payers, patients, and investors to plan for a new therapy’s rollout and breadth of patient access. This session will explore the early lessons from current value-based agreements to explain the payers’ expectations for future models of reimbursing treatments based on outcomes versus delivery.

view event >